CD274 and adenocarcinoma: In clinical analysis of adenocarcinoma patients with stage 1 (Fig. 8a, middle), patients with high PLK1/VIM/CD274 had shorter OS times than those with low PLK1/VIM/CD274 (n = 346, HR = 2.527, log rank P = 0.0246).